Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 2/20 | 0.37 |
| ▸ | ALAD | P13716 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.32 |
| ▸ | RORC | P51449 | 3/20 | 0.32 |
| ▸ | CTSS | P25774 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.32 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3345415 | 0.95 | HDAC1 (0.40) | HDAC1NPC1RAB9ASMN1; SMN2OPRM1 | |
| SCHEMBL12651151 | 0.88 | HDAC1 (0.42) | HDAC1NPC1RAB9ASMN1; SMN2OPRM1 | |
| Trifluoroacetic Acid SCHEMBL1785288 | 0.84 | RORC (0.44) | HDAC1NPC1RAB9ASMN1; SMN2OPRM1 | |
| Trifluoroacetic Acid SCHEMBL3342164 | 0.78 | RORC (0.47) | HDAC1NPC1RAB9ASMN1; SMN2OPRM1 | |
| Trifluoroacetic Acid SCHEMBL3339989 | 0.78 | OPRM1 (0.43) | HDAC1NPC1RAB9ASMN1; SMN2OPRM1 | |
| SCHEMBL3345422 | 0.77 | TP53 (0.38) | HDAC1NPC1RAB9ASMN1; SMN2CA2 | |
| Trifluoroacetic Acid SCHEMBL3345691 | 0.76 | HDAC1 (0.52) | HDAC1NPC1RAB9ASMN1; SMN2OPRM1 | |
| Trifluoroacetic Acid SCHEMBL3341662 | 0.76 | OPRM1 (0.43) | OPRM1OPRD1OPRK1KMT2ADRD4 | |
| SCHEMBL1787656 | 0.75 | OPRM1 (0.44) | HDAC1ALADNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1790026 | 0.74 | OPRM1 (0.44) | HDAC1OPRM1OPRD1OPRK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633175-B2 | Compounds as antagonists or inverse agonists at opioid receptors | GLAXOSMITHKLINE LLC (US) | 2014-01-21 | — | — | US | disclosed |
| US-20110124559-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | SMITHKLINE BEECHAM CORPORATION (US) | 2011-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124559-A1 | NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS | OPRL1, OPRM1, OPRK1 | HDAC1 2440/4885ALAD 4664/4885NPC1 3467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.